Fæcestransplantation som behandling af Clostridium difficile-infektion, colitis ulcerosa og metabolisk syndrom

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Fæcestransplantation som behandling af Clostridium difficile-infektion, colitis ulcerosa og metabolisk syndrom. / Carstensen, Jeppe West; Hansen, Axel Kornerup.

I: Ugeskrift for Laeger, Bind 176, Nr. 4, 2014, s. 337-340.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Carstensen, JW & Hansen, AK 2014, 'Fæcestransplantation som behandling af Clostridium difficile-infektion, colitis ulcerosa og metabolisk syndrom', Ugeskrift for Laeger, bind 176, nr. 4, s. 337-340.

APA

Carstensen, J. W., & Hansen, A. K. (2014). Fæcestransplantation som behandling af Clostridium difficile-infektion, colitis ulcerosa og metabolisk syndrom. Ugeskrift for Laeger, 176(4), 337-340.

Vancouver

Carstensen JW, Hansen AK. Fæcestransplantation som behandling af Clostridium difficile-infektion, colitis ulcerosa og metabolisk syndrom. Ugeskrift for Laeger. 2014;176(4):337-340.

Author

Carstensen, Jeppe West ; Hansen, Axel Kornerup. / Fæcestransplantation som behandling af Clostridium difficile-infektion, colitis ulcerosa og metabolisk syndrom. I: Ugeskrift for Laeger. 2014 ; Bind 176, Nr. 4. s. 337-340.

Bibtex

@article{62df0d360d394944b0576d0c89ea1765,
title = "F{\ae}cestransplantation som behandling af Clostridium difficile-infektion, colitis ulcerosa og metabolisk syndrom",
abstract = "Faecal transplantation as a treatment for Clostridium difficile infection, ulcerative colitis and the metabolic syndrome Faecal transplantation as a therapeutic tool is increasingly reported in the scientific literature. Faecal transplantation is currently becoming a treatment for nosocomial, refractory infections with C. difficile. Furthermore, faecal transplantation has been suggested as a treatment for ulcerative colitis as well as for the metabolic syndrome. In the accumulated literature faecal transplantations appear to be safe, effective and superior to current treatments. Faecal transplantation remains a sparsely investigated treatment, however, especially for other diagnoses than C. difficile infection.",
author = "Carstensen, {Jeppe West} and Hansen, {Axel Kornerup}",
year = "2014",
language = "Dansk",
volume = "176",
pages = "337--340",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "4",

}

RIS

TY - JOUR

T1 - Fæcestransplantation som behandling af Clostridium difficile-infektion, colitis ulcerosa og metabolisk syndrom

AU - Carstensen, Jeppe West

AU - Hansen, Axel Kornerup

PY - 2014

Y1 - 2014

N2 - Faecal transplantation as a treatment for Clostridium difficile infection, ulcerative colitis and the metabolic syndrome Faecal transplantation as a therapeutic tool is increasingly reported in the scientific literature. Faecal transplantation is currently becoming a treatment for nosocomial, refractory infections with C. difficile. Furthermore, faecal transplantation has been suggested as a treatment for ulcerative colitis as well as for the metabolic syndrome. In the accumulated literature faecal transplantations appear to be safe, effective and superior to current treatments. Faecal transplantation remains a sparsely investigated treatment, however, especially for other diagnoses than C. difficile infection.

AB - Faecal transplantation as a treatment for Clostridium difficile infection, ulcerative colitis and the metabolic syndrome Faecal transplantation as a therapeutic tool is increasingly reported in the scientific literature. Faecal transplantation is currently becoming a treatment for nosocomial, refractory infections with C. difficile. Furthermore, faecal transplantation has been suggested as a treatment for ulcerative colitis as well as for the metabolic syndrome. In the accumulated literature faecal transplantations appear to be safe, effective and superior to current treatments. Faecal transplantation remains a sparsely investigated treatment, however, especially for other diagnoses than C. difficile infection.

M3 - Tidsskriftartikel

AN - SCOPUS:84894334230

VL - 176

SP - 337

EP - 340

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 4

ER -

ID: 118397483